Twist Bioscience Corporation, a mid-cap growth and value equity company in the life sciences sector, has announced the granting of 72,991 equity awards to 36 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This comprises 53,600 restricted stock units (RSUs) and up to 19,379 performance stock units (PSUs). The RSUs vest over a 48-month period, with 25% vesting after one year and the remainder vesting quarterly, contingent on the employee's continued service. The PSUs are contingent on achieving specific performance metrics by the end of the 2027 fiscal year, with potential vesting between 50% to 140% of the target. These inducement awards comply with Nasdaq Listing Rule 5635(c)(4) and are intended as an incentive for new employees joining Twist Bioscience.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.